Medical Devices · Sunnyvale, California, United States
$19.49
+0.59% (+$0.11)2026-07-09
Smart-Money SignalDistribution · 39/100— Insiders are net sellers over 90 days (-$5.9M, 25 sales vs 8 buys)
Revenue$26.5M
Net Income-$19.7M
EPS$-0.52
Gross Margin87.3%
Market Cap$737.7M
Price Performance
Historical data including institutional events
Company Profile
X
Xingjuan Chao
CEO & Executive Director
CeriBell, Inc. operates as a medical technology company in the United States.
It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting.
The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm.
In addition, it operates an EEG portal, which enables real-time remote access to a patientâs EEG data.
The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015.
CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.